Published in Int J Colorectal Dis on May 29, 2009
Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: a clinical trial. Med Sci Monit (2014) 1.69
Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg (2010) 0.98
Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis (2011) 0.90
Dukes C colorectal cancer: is the metastatic lymph node ratio important? Int J Colorectal Dis (2011) 0.89
Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Ann Coloproctol (2013) 0.87
Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer. Surg Today (2011) 0.82
The prognostic value of lymph node ratio and updated TNM classification in rectal cancer patients with adequate versus inadequate lymph node dissection. Tech Coloproctol (2014) 0.81
Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Tech Coloproctol (2011) 0.81
Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer. J Korean Soc Coloproctol (2011) 0.79
A lymph node ratio of 10% is predictive of survival in stage III colon cancer: a French regional study. Int Surg (2014) 0.79
Prognostic Value of Lymph Node Ratio in Comparison to Lymph Node Metastases in Stage III Colon Cancer. Iran J Pathol (2015) 0.78
The role and prognostic impact of lymph node ratio on stage III colorectal cancer. Clujul Med (2013) 0.77
Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis. Oncotarget (2016) 0.75
Prognostic significance of lymph node ratio in patients with Merkel cell carcinoma. Eur Arch Otorhinolaryngol (2014) 0.75
Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst (2001) 5.68
Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst (2007) 5.48
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol (2005) 3.50
Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol (2002) 3.19
The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol (2003) 3.02
Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst (2005) 2.91
Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol (2007) 2.11
Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer (1967) 1.99
Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg (2002) 1.95
The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol (2002) 1.80
Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer (2005) 1.71
The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg (2004) 1.57
Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol (2008) 1.54
Ratios of involved nodes in early breast cancer. Breast Cancer Res (2004) 1.50
A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg (2002) 1.48
The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg (2007) 1.44
Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg (2002) 1.18
Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol (2005) 1.15
A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol (2008) 1.13
Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol (2004) 1.12
Prognostic value of the lymph node ratio in node positive colon cancer. Gut (2006) 1.07
Pelvic drainage and other risk factors for leakage after elective anterior resection in rectal cancer patients: a prospective study of 978 patients. Ann Surg (2005) 2.26
Management of patients with stercoral perforation of the sigmoid colon: report of five cases. World J Gastroenterol (2006) 1.73
Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol (2006) 1.50
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis (2010) 1.40
Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics (2006) 1.30
Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis (2011) 1.21
Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes (2010) 1.21
Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol Appl Pharmacol (2011) 1.17
Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum (2003) 1.13
Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction. J Am Soc Nephrol (2009) 1.11
Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol (2009) 1.11
Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon. Chang Gung Med J (2010) 1.08
The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer. Int J Colorectal Dis (2008) 1.06
Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am J Nephrol (2007) 1.05
Therapeutic options for proximal ureter stone: extracorporeal shock wave lithotripsy versus semirigid ureterorenoscope with holmium:yttrium-aluminum-garnet laser lithotripsy. Urology (2005) 1.03
Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum (2004) 0.99
Superoxide destabilization of beta-catenin augments apoptosis of high-glucose-stressed mesangial cells. Endocrinology (2008) 0.97
Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. J Med Virol (2008) 0.96
Risk factors associated with posthemorrhoidectomy secondary hemorrhage: a single-institution prospective study of 4,880 consecutive closed hemorrhoidectomies. Dis Colon Rectum (2002) 0.95
Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol (2012) 0.94
Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol (2011) 0.94
Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis (2003) 0.93
Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res (2013) 0.92
Iatrogenic femoral neuropathy following pelvic surgery: a rare and often overlooked complication--four case reports and literature review. Chang Gung Med J (2007) 0.90
Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol (2012) 0.90
Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Dis Colon Rectum (2005) 0.90
Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan. Cancer Genet Cytogenet (2005) 0.90
Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics (2012) 0.90
CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1. J Biomed Sci (2012) 0.90
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. J Biomed Sci (2014) 0.90
Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J Cell Physiol (2012) 0.89
Evaluation of contrast-enhanced computed tomographic colonography in detection of local recurrent colorectal cancer. World J Gastroenterol (2006) 0.89
Metastatic meningioma in the sacrum: a case report. Spine (Phila Pa 1976) (2002) 0.88
Ileocecal breast carcinoma metastasis. Int J Colorectal Dis (2004) 0.88
p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy. Cancer Lett (2004) 0.88
Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum. Ann Surg (2009) 0.87
High glucose-treated macrophages augment E-selectin expression in endothelial cells. J Biol Chem (2011) 0.87
Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in two branches of same institution. Int J Colorectal Dis (2010) 0.87
Randomized comparison between stapled hemorrhoidopexy and Ferguson hemorrhoidectomy for grade III hemorrhoids in Taiwan: a prospective study. Int J Colorectal Dis (2006) 0.86
Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol (2014) 0.85
Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated uropathogenic E. coli. Cell Microbiol (2011) 0.85
Massive lower gastrointestinal bleeding from an external iliac artery fistula in a patient with bladder cancer. Chang Gung Med J (2009) 0.84
Effective management of posthemorrhoidectomy secondary hemorrhage using rectal irrigation. Dis Colon Rectum (2002) 0.84
Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum (2006) 0.83
Clinical features of second other-site primary cancers among sporadic colorectal cancer patients--a hospital-based study of 3,722 cases. Hepatogastroenterology (2004) 0.83
Role of peroxiredoxin I in rectal cancer and related to p53 status. Int J Radiat Oncol Biol Phys (2010) 0.83
Clinical outcome of intersphincteric resection for ultra-low rectal cancer. World J Gastroenterol (2006) 0.82
Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence. Int J Colorectal Dis (2010) 0.82
Synchronous prostate stromal sarcoma and gastrointestinal stromal tumor of rectum: case report and review of the literature. Urology (2006) 0.82
Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. Int J Colorectal Dis (2007) 0.81
Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli. J Mol Med (Berl) (2014) 0.81
Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells. J Biomed Sci (2014) 0.81
Performing handsewn coloanal anastomosis with the pursestring suture anoscope. Dis Colon Rectum (2008) 0.80
Metastatic Merkel cell carcinoma in the rectum: report of a case. Dis Colon Rectum (2007) 0.80
Preoperative carcinoembryonic antigen elevation in colorectal cancer. Hepatogastroenterology (2011) 0.80
Carcinoma obstruction of the proximal colon cancer and long-term prognosis--obstruction is a predictor of worse outcome in TNM stage II tumor. Int J Colorectal Dis (2010) 0.80
Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer. Dis Colon Rectum (2006) 0.80
Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer. Int J Colorectal Dis (2011) 0.79
Concurrent chemoradiotherapy in the treatment of locally recurrent rectal cancer. Hepatogastroenterology (2013) 0.79
Calvatia lilacina protein-extract induces apoptosis through glutathione depletion in human colorectal carcinoma cells. J Agric Food Chem (2009) 0.79
Early prediction by 18F-FDG PET/CT for progression-free survival and overall survival in patients with metastatic colorectal cancer receiving third-line cetuximab-based therapy. Clin Nucl Med (2015) 0.79
Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer? Int J Colorectal Dis (2012) 0.79
Methylglyoxal-induced fibronectin gene expression through Ras-mediated NADPH oxidase activation in renal mesangial cells. Nephrology (Carlton) (2007) 0.78
Delayed ischemic gangrene change of distal limb despite optimal decompressed colostomy constructed in obstructed sigmoid colon cancer: a case report. World J Gastroenterol (2006) 0.78
Anorectal melanoma: review of 22 consecutive cases. Hepatogastroenterology (2013) 0.77
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases. Hepatogastroenterology (2012) 0.77
Measurement of physical activity in cancer survivors: a validity study. J Cancer Surviv (2013) 0.77
The late onset of an anal abscess caused by a chicken bone that complicated stapled hemorrhoidopexy. Int J Colorectal Dis (2006) 0.77
CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. J Cancer Res Clin Oncol (2014) 0.77